Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma
A new class of drugs that inhibits a "master switch" involved in the vast majority of cases of mantle cell
Read more
A new class of drugs that inhibits a "master switch" involved in the vast majority of cases of mantle cell
Read moreLymphoma is a cancer of the lymphatic system, which is part of the body’s germ-fighting network. The main two subtypes
Read moreA significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five
Read moreThe treatment of relapsed or refractory follicular lymphoma (RRFL) is distinct from patients who are receiving treatment for the first
Read moreEye cancers are treated by a team of specialists and doctors. This is called a multidisciplinary team approach. The team
Read moreLeukemia is the most common form of childhood cancers, with a prevalence rate of 10 – 45 per 100,0000 children
Read moreScientists at Scripps Research have demonstrated a promising new strategy for treating lymphomas, a group of cancers that begin in
Read moreIn a new study, researchers at Uppsala University have identified a previously unknown mechanism that regulates release of insulin, a
Read moreThe immune system is highly complex and a detailed understanding of many underlying mechanisms is still lacking. Only the precise
Read moreThis type of immunotherapy, called "checkpoint blockade," ramps up the ability of immune cells called T cells to fight cancer
Read more